SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art will provide featured remarks to the Harvard Business School on personalized medicine and venture capital on Thursday, March 29 in Boston, MA.
News | 03. 19. 2012
Art will provide featured remarks to the Harvard Business School on personalized medicine and venture capital on Thursday, March 29 in Boston, MA.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.